# Castle Biosciences, Inc. (CSTL): MoatMap facts

As of 29 Oct 2026. Research data, not investment advice.

As of 29 Oct 2026, MoatMap's StockRank for Castle Biosciences, Inc. (CSTL) is 55/100, ranked against 24,000+ stocks in 35 markets (Quality 48, Value 33, Momentum 68, each scored against its sector).

- StockRank: 55/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 48, Value 33, Momentum 68: each a 0-100 percentile within Healthcare.
- Position: #11,973 overall, #1,113 in Healthcare.
- Listing: United States, NGM; Healthcare / Diagnostics & Research.
- Last close: 36.68 USD on 28 Oct 2026.
- Insider filings, last 180 days: directors sold USD 9.7M.

Source: https://moatmap.ai/stock/CSTL
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker